unyango olutsha lomhlaza wemiphunga

Inkqubela phambili yamva nje kwi unyango olutsha lomhlaza wemiphunga zibonelela ngamazinga okuphila aphuculweyo kunye nomgangatho wobomi bezigulane. Ezi ziquka unyango olujoliswe kuyo, i-immunotherapies, kunye nobuchule obuphambili botyando. Ukuqonda olu khetho kunokuxhobisa izigulane kunye neentsapho zabo ukuba benze izigqibo ezinolwazi kunye nababoneleli babo bezempilo. Eli nqaku linika isishwankathelo sempumelelo yamva nje kunye neendlela zonyango ezifumanekayo.Ukuqonda uMhlaza weLung kunye nesidingo soNyango olutsha Umhlaza womphunga usengumngeni wezempilo obalulekileyo kwihlabathi jikelele. Kubalulekile ukuqonda iintlobo ezahlukeneyo zomhlaza wemiphunga kunye nezinto ezinegalelo ekukhuleni kwawo. Unyango lwesintu olufana nechemotherapy kunye nonyango lweradiation lunemida, lugxininisa imfuneko engxamisekileyo unyango olutsha lomhlaza wemiphunga amaqhinga.Iintlobo zoMhlaza weMiphungaZimbini iindidi eziphambili zezi: Umhlaza weMiphunga yeSeli engeNcinane (NSCLC): Olu lolona hlobo luqhelekileyo, lubalelwa malunga ne-80-85% yezehlo zomhlaza wemiphunga. Iintlobo ezincinci ziquka i-adenocarcinoma, i-squamous cell carcinoma, kunye ne-cell carcinoma enkulu. Umhlaza weMiphunga yeSeli encinci (SCLC): Olu hlobo aluxhaphakanga kwaye luthanda ukukhula kwaye lunwenwe ngokukhawuleza ngakumbi kune-NSCLC.Uqhaqho kwi-Targeted Therapy for Lung Cancer. unyango olutsha lomhlaza wemiphunga egxininisa kwiimolekyuli ezithile ezibandakanyekayo ekukhuleni kweeseli zomhlaza kunye nokuphila. Ngokungafaniyo ne-chemotherapy, ehlasela zonke iiseli ezahlula-hlula ngokukhawuleza, unyango olujoliswe kulo lujolise ekubulaleni iiseli zomhlaza ngelixa usindisa ezisempilweni. Oku kudla ngokukhokelela kwiziphumo ebezingalindelekanga ezimbalwa.Ii-Common Targeted Therapies kunye neeThagethi zazoIindlela zonyango ekujoliswe kuzo ezininzi ngoku zivunyiwe ukuba zisetyenziswe kwiintlobo ezithile ze-NSCLC. Olu nyango luhlala lujolise kwiinguqu zemfuza ezifana ne-EGFR, ALK, ROS1, BRAF, MET, kunye ne-NTRK. Umzekelo ocetyiweyo weChiza oluNgxamisekileyo lwe-NSCLC Uhlobo lwe-EGFR Osimertinib (Tagrisso) NSCLC ene-EGFR iinguqulelo ze-ALK Alectinib (Alecensa) NSCLC enohlengahlengiso lwe-ALK ROS1 Entrectinib (Rozlytrek) NSCLC enohlengahlengiso lwe-ROS1 Umthombo: Umbutho womhlaza waseMelikaIndima yoVavanyo lwe-BiomarkerNgaphambi kokuqala unyango olujoliswe kuyo, uvavanyo lwe-biomarker lubalulekile. Olu vavanyo lubandakanya ukuhlalutya isampulu yethumba lesigulane ukuchonga utshintsho oluthile lwemfuza okanye ukungahambi kakuhle kweprotheyini. Iziphumo zovavanyo lwe-biomarker zinceda oogqirha babone ukuba isigulana sinokuzuza kunyango oluthile olujoliswe kuyo. I IZiko loPhando ngoMhlaza laseShandong Baofa igxininisa ukubaluleka koxilongo oluchanekileyo lonyango olusebenzayo.Immunotherapy: Ukuqinisa i-Immune System ukulwa noMhlaza weLungImmunotherapy imele enye inkqubela phambili ebalulekileyo unyango olutsha lomhlaza wemiphunga. Le ndlela isebenza ngokuvuselela amajoni omzimba wesigulana ukuba aqaphele kwaye ahlasele iiseli zomhlaza. Iziyobisi ze-Immunotherapy, ezifana ne-checkpoint inhibitors, i-blockpoint inhibitors, iiprotheni ezithintela amajoni omzimba ekuhlaseleni iiseli zomhlaza.Iintlobo ze-Immunotherapy Drugs for Lung CancerAmachiza aqhelekileyo asetyenziswa kunyango lomhlaza wemiphunga aquka: PD-1 inhibitors: Pembrolizumab (Keytruda), Nivolumab (Opdivo) PD-L1 inhibitors: Atezolizumab (Tecentriq), Durvalumab (Imfinzi) I-CTLA-4 inhibitors: I-Ipilimumab (Yervoy) (ehlala isetyenziswa ngokudityaniswa ne-PD-1 inhibitor) Ngubani oMviwa wokufumana unyango lwe-Immunotherapy? Isigqibo sokusebenzisa i-immunotherapy sixhomekeke kwizinto eziliqela, kuquka uhlobo kunye nenqanaba lomhlaza wemiphunga, impilo yesigulana iyonke, kunye nenqanaba lokubonakaliswa kwe-PD-L1 kwiiseli zethumba. I-PD-L1 yiprotheyini enokunceda iiseli zomhlaza ukuba zibaleke amajoni omzimba. Izigulane ezinenkcazo ephezulu ye-PD-L1 ziyakwazi ukuphendula kwi-immunotherapy. I-oncologist yezonyango iya kuvavanya ngononophelo isigulane ngasinye ukuze ibone ukuba i-immunotherapy ifanelekile na. unyango olutsha lomhlaza wemiphunga, ngakumbi kwi-NSCLC yasekuqaleni. Ukuqhubela phambili kwiinkqubo zokuhlinzwa kuye kwakhokelela kwiinkqubo ezingaphantsi kunye neziphumo eziphuculweyo.I-Minimally Invasive SurgeryI-invasive techniquesI-invasive techniques, ezifana ne-video-assisted thoracoscopic surgery (VATS) kunye nokuhlinzwa kwe-robotic, vumela oogqirha botyando ukuba basuse i-tumor ngokusebenzisa iindawo ezincinci. Ezi ndlela zobugcisa zibonelela ngeenzuzo ezininzi kunotyando oluvulelekileyo lwesintu, kubandakanywa iintlungu ezisezantsi, ukuhlala ixesha elifutshane esibhedlele, kunye namaxesha akhawulezayo okuchacha.I-Stereotactic Body Radiotherapy (SBRT)Nangona ingelulo utyando olungqongqo, i-SBRT luhlobo oluchane kakhulu lonyango lwemitha olunokusetyenziswa ukunyanga umhlaza wemiphunga okwinqanaba lokuqala kwizigulane ezingabafanelanga utyando. I-SBRT inikezela ngeedosi eziphezulu zemitha yemitha kwithumba ngelixa inciphisa ukuvezwa kwisihlunu esisempilweni esingqongileyo. unyango olutsha lomhlaza wemiphunga kubandakanya ukudibanisa iindlela ezahlukeneyo zonyango. Ngokomzekelo, izigulane zinokufumana i-chemotherapy elandelwa lutyando, okanye unyango olujoliswe kuyo ngokudibanisa ne-immunotherapy. Indibaniselwano ethile yonyango iya kuxhomekeka kwimeko yesigulana ngasinye. Ukubaluleka kovavanyo lwezonyango Ulingo lwezonyango ludlala indima ebalulekileyo ekuphuhliseni unyango olutsha lomhlaza wemiphunga izicwangciso. Olu lingo luvavanya ukhuseleko kunye nokusebenza kwamachiza amatsha kunye neendlela zonyango. Izigulana ezithatha inxaxheba kulingo lwezonyango zinokuba nofikelelo kunyango olukwinqanaba eliphezulu olungekafumaneki ngokubanzi. Cinga ngokuxoxa ngeendlela zovavanyo lweklinikhi kunye ne-oncologist yakho. Ulwazi malunga nemizila yeklinikhi enxulumene nophando lomhlaza inokufumaneka kwi IZiko loPhando ngoMhlaza laseShandong Baofa website.Ukuphila NoMhlaza Wemiphunga: Inkxaso kunye neZiboneleloUkuxilongwa komhlaza wemiphunga kunokongamela. Kubalulekile ukufuna inkxaso kubasebenzi bezempilo, kusapho, kubahlobo nakumaqela enkxaso. Imibutho emininzi inikezela ngezibonelelo kunye neenkonzo zokunceda izigulane kunye neentsapho zazo ukumelana nemingeni yokuphila nomhlaza wemiphunga.IsipheloInkqubela phambili ebonakalayo yenziwe kwi unyango olutsha lomhlaza wemiphunga kwiminyaka yakutshanje. Unyango ekujoliswe kulo, i-immunotherapies, kunye neendlela eziphambili zotyando zinika ithemba elitsha kwizigulana ezinomhlaza wemiphunga. Ngokuhlala unolwazi malunga nenkqubela phambili yamva nje kunye nokusebenza ngokusondeleyo neqela labo lezempilo, izigulana zinokwenza izigqibo ezinolwazi kwaye ziphucule amathuba azo okuphila kunye nomgangatho wobomi.